Poly (ADP-ribose) polymerase (PARP) as target for the treatment of epithelial ovarian cancer: what to know.
Poly (ADP-ribose) polymerase (PARP) inhibitors are being developed in maintenance and recurrence...
Read More
Hematology/Oncology
The results of multigene panel sequencing in Slovak HBOC families.
Hereditary breast and ovarian cancer (HBOC) is primarily associated with mutations in the BRCA1/2...
Read More
Non-contrast MRI can accurately characterize adnexal masses: a retrospective study.
To determine the accuracy of interpretation of a non-contrast MRI protocol in characterizing...
Read More
Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer
TUESDAY, March 16, 2021 (HealthDay News) — For people with HIV, deferral of antiretroviral...
Read More
COVID-19 Impacting Caregivers of Children With Cancer
MONDAY, March 15, 2021 (HealthDay News) — Caregivers of childhood cancer survivors are...
Read More
Pooled Analysis Shows Men Have Higher Mortality Than Women
MONDAY, March 15, 2021 (HealthDay News) — Men have higher mortality than women, with...
Read More
AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
MONDAY, March 15, 2021 (HealthDay News) — There is no scientific evidence linking the...
Read More
US Breast Cancer Centers Recommend Earlier Initiation of Screening
MONDAY, March 15, 2021 (HealthDay News) — Most U.S. breast cancer centers recommend that...
Read More
Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Targeting cell division by chemotherapy is a highly effective strategy to treat a wide range of...
Read More
Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Y box binding protein 1 (YB-1) is a multifunctional protein associated with tumor progression and...
Read More
Gene expression in the angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study.
Clinical studies suggest altered systemic vascular biology in cancer patients. We assessed...
Read More
Gene Therapy for Sickle Cell Did Not Cause Patient’s Leukemia
THURSDAY, March 11, 2021 (HealthDay News) — There is no evidence that a promising gene...
Read More
Guidance Offered for Improving Diversity in Multiple Myeloma Trials
WEDNESDAY, March 10, 2021 (HealthDay News) — In an initiative from the Dana-Farber Cancer...
Read More
Whole-Genome Sequencing Is Accurate for Myeloid Cancers
WEDNESDAY, March 10, 2021 (HealthDay News) — A streamlined whole-genome sequencing approach...
Read More
Many Women Feel Left Out of Decisions on Breast Cancer Care
THURSDAY, March 11, 2021 (HealthDay News) — There is significant divergence between...
Read More
One in Five Health Care Workers Reports Mental Health Conditions
THURSDAY, March 11, 2021 (HealthDay News) — Globally, among health care workers, there has...
Read More
The Non-Alcoholic Fatty Liver cause of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the fourth most prevalent cause of cancer-related death...
Read More
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer.
Fc fragment of IgG-binding protein (FCGBP) is differentially expressed in various tumors. However,...
Read More
A biphasic response of polymerized Type 1 collagen architectures to dermatan sulfate.
Collagen I, the most abundant extracellular matrix (ECM) protein in vertebrate tissues provides...
Read More
R-catcher, a potent molecular tool to unveil the arginylome.
Protein arginylation is a critical regulator of a variety of biological processes. The ability to...
Read More